Upadacitinib for Refractory Behcet's Syndrome: A Multi-center, Prospective, Open-label, Pilot Study

被引：0
|
作者：
Xia, Weiyi [1 ]
Li, Jiachen [1 ]
Liu, Tian [1 ]
Li, Yuhui [2 ]
机构：
[1] Peking Univ, Peoples Hosp, Beijing, Peoples R China
[2] Peking Univ, Beijing, Peoples R China
来源：
ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2515
引用
收藏
页码：5121 / 5122
页数：2
相关论文
共 50 条
  • [1] A PROSPECTIVE OPEN-LABEL SINGLE CENTER STUDY OF ADALIMUMAB IN BEHCET ARTHRITIS
    Braun-Moscovici, Y.
    Tavor, Y.
    Markovits, D.
    Naffaa, M.
    Toledano, K.
    Rozin, A.
    Beshara-Garzoz, R.
    Nahir, M. A.
    Balbir-Gurman, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1103 - 1103
  • [2] A multi-center, open-label, pilot study of allograft adipose matrix for the correction of atrophic temples
    Gold, Michael H.
    Kinney, Brian M.
    Kaminer, Michael S.
    Rohrich, Rod J.
    D'Amico, Richard A.
    JOURNAL OF COSMETIC DERMATOLOGY, 2020, 19 (05) : 1044 - 1056
  • [3] Etanercept therapy for immune-mediated cochleovestibular disorders: A multi-center, open-label, pilot study
    Matteson, EL
    Choi, HK
    Poe, DS
    Wise, C
    Lowe, VJ
    Mcdonald, TJ
    Rahman, MU
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2005, 53 (03): : 337 - 342
  • [4] Canakinumab for Behcet's Disease Resistant to Standard Treatment (CanBeDisT) - an open-label single center pilot study
    Koetter, I.
    Deuter, C.
    Henes, J.
    Xenitidis, T.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (06) : S187 - S187
  • [5] Rituximab for refractory Wegener's granulomatosis - Report of a prospective, open-label pilot trial
    Keogh, KA
    Ytterberg, SR
    Fervenza, FC
    Carlson, KA
    Schroeder, DR
    Specks, U
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 173 (02) : 180 - 187
  • [6] Hospital-Based Korean Diabetes Prevention Study: A Prospective, Multi-Center, Randomized, Open-Label Controlled Study
    Rhee, Sang Youl
    Chon, Suk
    Ahn, Kyu Jeung
    Woo, Jeong-Taek
    Lee, Moon-Kyu
    Park, Kyong Soo
    Cha, Bong Soo
    Baik, Sei-Hyun
    Park, Joong Yeol
    Lee, Kwan Woo
    Lee, In-Kyu
    Park, Tae Sun
    Kim, In Joo
    Lee, Jung Min
    Lee, Jung Hwa
    Lim, Jeong Hyun
    Cho, Jae Won
    Kweon, Meera
    Lee, Ji-Hyun
    Cho, Young Jung
    Lee, Jee-Hyun
    Lim, Sung-Chul
    Choi, Jin Sun
    Hong, Jeongim
    Lim, Hyun Jung
    Cho, Dong-Hyeok
    Chun, Sung Wan
    Kim, So Hun
    Sohn, Seo Young
    Lee, Hyeok
    Hwang, You Cheol
    Jeon, Justin Y.
    Lee, Mi Kyoung
    Kang, Eunjeong
    Choi, Jihye
    DIABETES & METABOLISM JOURNAL, 2019, 43 (01) : 49 - 58
  • [7] Efficacy and safety of paliperidone ER in patients with first episode psychosis: An open-label, prospective, multi-center study
    Chung, Y. -C.
    Park, J. -I.
    Cho, D. -H.
    Hahn, S. -W.
    Han, C.
    Jung, M. H.
    Kim, J. -H.
    Kim, S. -W.
    Lee, K. Y.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 67 - 67
  • [8] Effectiveness of quetiapine in patients with bipolar I and II depression: A multi-center, prospective, open-label, observational study
    Jeong, J. -H.
    Bahk, W. -M.
    Woo, Y. S.
    Seo, H. -J.
    Hong, S. -C.
    Jon, D. -I.
    Cho, H. -S.
    Yoo, S. Y.
    Min, K. J.
    Yoon, B. -H.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 126 - 126
  • [9] Rituximab for refractory polymyositis: An open-label prospective study
    Mok, Chi Chiu
    Ho, Ling Yin
    To, Chi Hung
    JOURNAL OF RHEUMATOLOGY, 2007, 34 (09) : 1864 - 1868
  • [10] A multi-center, open-label, randomized study to explore efficacy and safety of baricitinib in active primary Sjogren's syndrome patients
    Bai, Wei
    Yang, Fan
    Xu, Huji
    Wei, Wei
    Li, Hongbin
    Zhang, Liyun
    Zhao, Yi
    Shi, Xiaofei
    Zhang, Yan
    Zeng, Xiaofeng
    Leng, Xiaomei
    TRIALS, 2023, 24 (01)
12345